Learning Objectives

  1. Describe temporomandibular disorder (TMD) pathophysiology, diagnosis, and management
  2. Describe fibromyalgia pathophysiology, diagnosis, and gender and psychological considerations 
  3. Define pharmacologic treatment options for TMD and fibromyalgia
  4. Identify non-pharmacologic and complementary and alternative medicine (CAM) pain management strategies


Co-investigator Acknowledgements

Brigham and Women’s Hospital

  • Antje Barreveld, M.D.
  • Robert Jamison, Ph.D. 
  • Jennifer McSweeney, M.D. 
  • Ajay Wasan, M.D., M.Sc. 

Harvard School of Dental Medicine

  • Jeffry Shaefer, D.D.S, M.S., M.P.H 
  • Nicole Holland, D.D.S., M.S. 
  • David Keith, B.D.S., F.D.S., R.C.S., D.M.D 

Harvard Medical School

  • Julia Whelan

Massachusetts College of Pharmacy and Health Sciences

  • Michele Matthews, PharmD

Massachusetts General Hospital

  • Paul Arnstein, Ph.D., R.N. 

Additional acknowledgements for their contributions to the development of this case: Robert Edwards, Ph.D., Theresa Melnikas, R.N., D.N.P., Laurie M. Lauzon Clabo, Ph.D., R.N., Kenneth Almeida, PharmD Candidate 2014








Harvard University logo
Harvard University